Natural products repurposing of the H5N1-based lead compounds for the most fit inhibitors against 3C-like protease of SARS-CoV-2
Context: COVID-19 pandemic has caused more than 2.7 million mortality worldwide. Although the COVID-19 vaccine has been developed, the amount is still limited, and very few countries have reached ‘herd immunity’ level. In this regard, imported and community infections is still happening in the world...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA)
2021-09-01
|
Series: | Journal of Pharmacy & Pharmacognosy Research |
Subjects: | |
Online Access: | https://jppres.com/jppres/pdf/vol9/jppres21.1080_9.5.730.pdf |